- Home
- CRBP vs FDSB Comparison
CRBP vs FDSB Comparison
Compare CRBP & FDSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRBP
- FDSB
- Stock Information
- Founded
- CRBP 2009
- FDSB 1926
- Country
- CRBP United States
- FDSB United States
- Employees
- CRBP N/A
- FDSB N/A
- Industry
- CRBP Biotechnology: Pharmaceutical Preparations
- FDSB
- Sector
- CRBP Health Care
- FDSB
- Exchange
- CRBP Nasdaq
- FDSB NYSE
- Market Cap
- CRBP 73.4M
- FDSB 68.2M
- IPO Year
- CRBP N/A
- FDSB N/A
- Fundamental
- Price
- CRBP $5.31
- FDSB $12.34
- Analyst Decision
- CRBP Strong Buy
- FDSB
- Analyst Count
- CRBP 10
- FDSB 0
- Target Price
- CRBP $60.89
- FDSB N/A
- AVG Volume (30 Days)
- CRBP 213.2K
- FDSB 5.1K
- Earning Date
- CRBP 03-11-2025
- FDSB 05-15-2025
- Dividend Yield
- CRBP N/A
- FDSB N/A
- EPS Growth
- CRBP N/A
- FDSB N/A
- EPS
- CRBP N/A
- FDSB N/A
- Revenue
- CRBP N/A
- FDSB $10,664,000.00
- Revenue This Year
- CRBP N/A
- FDSB N/A
- Revenue Next Year
- CRBP $270.01
- FDSB N/A
- P/E Ratio
- CRBP N/A
- FDSB N/A
- Revenue Growth
- CRBP N/A
- FDSB N/A
- 52 Week Low
- CRBP $5.12
- FDSB $9.85
- 52 Week High
- CRBP $61.90
- FDSB $14.50
- Technical
- Relative Strength Index (RSI)
- CRBP 27.45
- FDSB N/A
- Support Level
- CRBP $5.76
- FDSB N/A
- Resistance Level
- CRBP $6.17
- FDSB N/A
- Average True Range (ATR)
- CRBP 0.39
- FDSB 0.00
- MACD
- CRBP 0.03
- FDSB 0.00
- Stochastic Oscillator
- CRBP 9.73
- FDSB 0.00
About CRBP Corbus Pharmaceuticals Holdings Inc.
Corbus Pharmaceuticals Holdings Inc is a precision oncology company with a diversified portfolio and is committed to helping people defeat serious illness by bringing scientific approaches to well-understood biological pathways. The company's development pipeline includes; CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells, and CRB-913 a second-generation peripherally restricted CB1 receptor inverse agonist designed to treat obesity.
About FDSB FIFTH DISTRICT BANCORP INC.
Fifth District Bancorp inc is a holding company of Fifth District. Fifth District portfolio consists primarily of fixed-rate one- to four-family residential mortgage loans also originate construction loans, home equity loans, home equity lines of credit, land loans, and share loans (loans secured by deposit accounts at Fifth District) and purchase commercial business loans. The company offer a variety of deposit accounts including checking accounts, money market accounts, and certificates of deposit. In addition, it offers electronic banking services including mobile banking, on-line banking, telephone banking, bill pay, and electronic funds transfer via SmartPay.